139 related articles for article (PubMed ID: 26323462)
1. Evaluation of a combinatorial RNAi lentivirus vector targeting foot-and-mouth disease virus in vitro and in vivo.
Zhang X; Zheng H; Xu M; Zhou Y; Li X; Yang F; Liu Q; Shi D
Mol Med Rep; 2015 Nov; 12(5):6672-8. PubMed ID: 26323462
[TBL] [Abstract][Full Text] [Related]
2. Identification of short hairpin RNA targeting foot-and-mouth disease virus with transgenic bovine fetal epithelium cells.
Wang H; Wu J; Liu X; He H; Ding F; Yang H; Cheng L; Liu W; Zhong J; Dai Y; Li G; He C; Yu L; Li J
PLoS One; 2012; 7(8):e42356. PubMed ID: 22905125
[TBL] [Abstract][Full Text] [Related]
3. Transgenically mediated shRNAs targeting conserved regions of foot-and-mouth disease virus provide heritable resistance in porcine cell lines and suckling mice.
Jiao Y; Gong X; Du J; Liu M; Guo X; Chen L; Miao W; Jin T; Chang H; Zeng Y; Zheng Z
Vet Res; 2013 Jul; 44(1):47. PubMed ID: 23822604
[TBL] [Abstract][Full Text] [Related]
4. Attenuated Salmonella choleraesuis-mediated RNAi targeted to conserved regions against foot-and-mouth disease virus in guinea pigs and swine.
Cong W; Jin H; Jiang C; Yan W; Liu M; Chen J; Zuo X; Zheng Z
Vet Res; 2010; 41(3):30. PubMed ID: 20167192
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of foot-and-mouth disease virus replication in vitro and in vivo by small interfering RNA.
Pengyan W; Yan R; Zhiru G; Chuangfu C
Virol J; 2008 Jul; 5():86. PubMed ID: 18652701
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-vectored shRNAs targeted to the highly conserved regions of VP1 and 2B in tandem inhibits replication of foot-and-mouth disease virus both in vitro and in vivo.
Xu YF; Shen HY; Zhao MQ; Chen LJ; Li YG; Liao M; Jia JT; Lv YR; Yi L; Chen JD
J Virol Methods; 2012 Apr; 181(1):51-8. PubMed ID: 22327142
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo.
Chen W; Liu M; Jiao Y; Yan W; Wei X; Chen J; Fei L; Liu Y; Zuo X; Yang F; Lu Y; Zheng Z
J Virol; 2006 Apr; 80(7):3559-66. PubMed ID: 16537624
[TBL] [Abstract][Full Text] [Related]
8. RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice.
Chen W; Yan W; Du Q; Fei L; Liu M; Ni Z; Sheng Z; Zheng Z
J Virol; 2004 Jul; 78(13):6900-7. PubMed ID: 15194766
[TBL] [Abstract][Full Text] [Related]
9. Silencing of the foot-and-mouth disease virus internal ribosomal entry site by targeting relatively conserved region among serotypes.
Matsui T; Handa Y; Kanda T; Tsukiyama-Kohara K
Virus Genes; 2019 Dec; 55(6):786-794. PubMed ID: 31367998
[TBL] [Abstract][Full Text] [Related]
10. The plasmid constructs producing shRNA corresponding to the conserved 3D polymerase of Foot and Mouth Disease virus protects guinea pigs against challenge virus.
Joyappa DH; Sasi S; Ashok KC; Reddy GR; Suryanarayana VV
Vet Res Commun; 2009 Mar; 33(3):263-71. PubMed ID: 18810649
[TBL] [Abstract][Full Text] [Related]
11. Transient inhibition of foot-and-mouth disease virus replication by siRNAs silencing VP1 protein coding region.
Lv K; Guo Y; Zhang Y; Wang K; Li K; Zhu Y; Sun S
Res Vet Sci; 2009 Jun; 86(3):443-52. PubMed ID: 19062053
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic application of RNA interference against foot-and-mouth disease virus in vitro and in vivo.
Kim SM; Lee KN; Park JY; Ko YJ; Joo YS; Kim HS; Park JH
Antiviral Res; 2008 Nov; 80(2):178-84. PubMed ID: 18601955
[TBL] [Abstract][Full Text] [Related]
13. Genetic Determinants of Altered Virulence of Type O Foot-and-Mouth Disease Virus.
Yang F; Zhu Z; Cao W; Liu H; Wei T; Zheng M; Zhang K; Jin Y; He J; Guo J; Liu X; Zheng H
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915277
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mouse model integrating siRNA targeting the foot and mouth disease virus.
Pengyan W; Jianjun J; Ning L; Jinliang S; Yan R; Chuangfu C; Zhiru G
Antiviral Res; 2010 Aug; 87(2):265-8. PubMed ID: 20176056
[TBL] [Abstract][Full Text] [Related]
15. shRNA transgenic swine display resistance to infection with the foot-and-mouth disease virus.
Hu W; Zheng H; Li Q; Wang Y; Liu X; Hu X; Liu W; Liu S; Chen Z; Feng W; Cai X; Li N
Sci Rep; 2021 Aug; 11(1):16377. PubMed ID: 34385528
[TBL] [Abstract][Full Text] [Related]
16. Genetic Determinants of Virulence between Two Foot-and-Mouth Disease Virus Isolates Which Caused Outbreaks of Differing Severity.
Nishi T; Morioka K; Saito N; Yamakawa M; Kanno T; Fukai K
mSphere; 2019 Aug; 4(4):. PubMed ID: 31413173
[TBL] [Abstract][Full Text] [Related]
17. Cross-inhibition to heterologous foot-and-mouth disease virus infection induced by RNA interference targeting the conserved regions of viral genome.
Liu M; Chen W; Ni Z; Yan W; Fei L; Jiao Y; Zhang J; Du Q; Wei X; Chen J; Liu Y; Zheng Z
Virology; 2005 May; 336(1):51-9. PubMed ID: 15866070
[TBL] [Abstract][Full Text] [Related]
18. Induction of protection against foot-and-mouth disease virus in cell culture and transgenic suckling mice by miRNA targeting integrin αv receptor.
Du J; Guo X; Gao S; Luo J; Gong X; Hao C; Yang B; Lin T; Shao J; Cong G; Chang H
J Biotechnol; 2014 Oct; 187():154-61. PubMed ID: 25016204
[TBL] [Abstract][Full Text] [Related]
19. Lentviral-mediated RNAi to inhibit target gene expression of the porcine integrin αv subunit, the FMDV receptor, and against FMDV infection in PK-15 cells.
Luo J; Du J; Gao S; Zhang G; Sun J; Cong G; Shao J; Lin T; Chang H
Virol J; 2011 Sep; 8():428. PubMed ID: 21899738
[TBL] [Abstract][Full Text] [Related]
20. A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice.
Yang B; Lan X; Li X; Yin X; Li B; Han X; Li Y; Zhang Z; Liu J
Vaccine; 2008 Oct; 26(43):5477-83. PubMed ID: 18694793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
